Switzerland· 67423002
Agomelatin Spirig HC
A agomelatin product containing agomelatinum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Agomelatin is registered in 13 of 19 countries.
Countries holding a registration under ATC N06AX22 (agomelatin), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 9 of them publish a price we can compare per daily dose
Agomelatin · ATC N06AX22
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
Price per daily dose
What a daily dose of agomelatin costs, country by country.
Normalised to the WHO defined daily dose (25 mg), the median price runs from $0.72 in France to $1.72 in Switzerland — a ×2.4 gap.
- Switzerland: $1.72 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Agomelatin · price per daily dose (25 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.72
- FR France$0.72
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- agomelatinum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- N06AX22
- ATC class
- Agomelatin
- Defined daily dose
- 25 mg, O
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680674230021Blist 98 StkCHF 113.15
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
25 interactions on record for agomelatin.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Agomelatin · interactions on record
25 records
25 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Agomelatin in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainAGLONEX 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAccord Healthcare S.L.U.
- NetherlandsAgomaval 25 mg, filmomhulde tablettenKrka d.d., Novo mesto
- FranceAGOMELATINE BIOGARAN 25 mg, comprimé pelliculéBIOGARAN
- PolandAgolekPrzedsiębiorstwo Farmaceutyczne LEK-AM Sp. z o.o.
- CzechiaVALDOXANLes Laboratoires Servier, Suresnes cedex
- FinlandAgomelatine AnpharmAnpharm Przedsiebiorstwo Farmaceutyczne S.A.
- SwedenAgomelatin Glenmark 25 mg Filmdragerad tablettGlenmark Arzneimittel GmbH
- IcelandAgomelatine STADASTADA Arzneimittel AG
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Agogerolan, Agomelatin Genericon
- Bulgaria · Агомелатин G.L. Pharma
- Czechia · Agomelatin +pharma, Agomelatine G.L.Pharma
- Germany · Agomaval, Agomelatin Abz
- Denmark · Agomelatin Glenmark, Agomelatin Stada
- Estonia · Lamegom
- Spain · Agomelatina Aurovitas Spain, Agomelatina Qualigen
- Finland · Agomelatine Stada, Agomelatine Viatris
- France · Agomelatine Biogaran, Agomelatine Eg
- United Kingdom (Northern Ireland) · Agomelatine Accord, Agomelatine Neuraxpharm
- Hungary · Agomelatin Teva, Agomelatine Anpharm
- Ireland · Agomelatine Viatris
- Iceland · Agomelatine Stada, Valdoxan
- Liechtenstein · Valdoxan
- Lithuania · Agomelatine Anpharm, Lamegom
- Malta · Agomaval
- Netherlands · Agomaval, Agomelatine Accord
- Norway · Valdoxan
- Poland · Agolek, Agomelatine +pharma
- Portugal · Agomelatina Ciclum, Agomelatina Generis
- Sweden · Agomelatin Glenmark, Agomelatine Stada
- Slovakia · Agomelatín Stada, Agomelatine G.L. Pharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e698359d-a771-4293-9c4f-9e273c232298 GET /v1/drugs/e698359d-a771-4293-9c4f-9e273c232298?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "agomelatinum 25 mg",
"valid_from": "2020-11-01",
"limitations": "[{\"description\":\"Keine Kostenübernahme bei Patienten, die bei Therapiebeginn >= 65 Jahre alt sind und noch nie mit Agomelatin behandelt wurden.<br>\\n<br>\\n\",\"costApproval\":null,\"indication\":null,\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2020-11-01\",\"validTo\":null}]",
"galenic_form": "Filmtabl 25 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2020-11-01",
"self_retention_pct": 10
}See everything about agomelatin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.